Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Astellas Pharma Ltd

Below is an extended Astellas Pharma Ltd news listing. Click here to return to the Astellas Pharma Ltd main Biocorporate entry.

BioNews Results for Astellas Pharma Ltd:
Central Nervous System Disorders Therapy - Researchers from Astellas Pharma, Inc. discuss findings in central NewsRX: Nov 23 2009 8:31AM Matching: astellas pharma
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome SmartBrief: Nov 20 2009 6:49AM Matching: astellas pharma
Rising Sun, Falling Stocks: Nintendo, Kyocera, Takeda Pharma, Nippon Telephone & Telegraph Guru Focus: Nov 20 2009 1:17PM Matching: astellas pharma
Astellas Pharma and XenoPort submit NDA in Japan for PMDA approval News-Medical.Net: Nov 19 2009 12:49PM Matching: astellas pharma
XenoPort (XNPT) and Astellas Pharma Announce an Application for RLS Treatment XP13512 Filed with PMDA in Japan Street Insider: Nov 19 2009 12:21PM Matching: astellas pharma
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP88 Pharmacy Choice: Nov 19 2009 10:39PM Matching: astellas pharma
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP88 Genetic Engineering News: Nov 19 2009 1:59PM Matching: astellas pharma
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP88 Pharma Live: Nov 19 2009 1:14PM Matching: astellas pharma
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA... Forbes.com: Nov 19 2009 12:01PM Matching: astellas pharma
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome FinanzNachrichten.de: Nov 19 2009 11:40AM Matching: astellas pharma
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome Stockwatch: Nov 19 2009 11:37AM Matching: astellas pharma
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval PR inside: Nov 19 2009 11:36AM Matching: astellas pharma
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP88 NewsBlaze: Nov 19 2009 12:14PM Matching: astellas pharma
XenoPort, Astellas Pharma Submit NDA For ASP8825 For Restless Legs Syndrome In Japan - Quick Facts RTTNews.com: Nov 19 2009 12:11PM Matching: astellas pharma
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome Business Wire UK: Nov 19 2009 11:35AM Matching: astellas pharma

«Astellas Pharma Ltd

This page contained an extended Astellas Pharma Ltd news listing. Click here to return to the Astellas Pharma Ltd main Biocorporate entry.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.